Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 1475 entries
View as:

Study of the Safety & PK of INX-08189 in Chronically-infected HCV, Treatment-naïve Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01250366 Org: User:
Start: 10/31/10 End: 06/30/11 Due: 06/30/12

A Study of BMS-986195 in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03245515 Org: User:
Start: 08/15/17 End: 10/05/17 Due: 10/05/18

A Study of Abatacept in Participants That Only Recently Started to Develop Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT03457792 Org: User:
Start: 04/17/18 End: 03/30/22 Due: 03/30/23

An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo and a Currently Available Treatment in Participants With Moderate-to-Severe Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT03611751 Org: User:
Start: 07/26/18 End: 11/30/20 Due: 11/30/21

Survey on Long-Term Use of ORENCIA® Intravenous Infusion 250mg

Phase: N/A Priority: Normal
NCT ID: NCT02600468 Org: User:
Start: 09/30/13 End: 12/31/15 Due: 12/31/16

Comparison of Ipilimumab Manufactured by 2 Different Processes in Participants With Advanced Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00920907 Org: User:
Start: 08/31/09 End: 10/31/12 Due: 10/31/13

A Study to Assess the Effects of 2 Prothrombin Complex Concentrates on the Pharmacodynamics of Apixaban in Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02074358 Org: User:
Start: 02/28/14 End: 04/30/14 Due: 04/30/15

Effect on the Electrocardiographic QT Interval Corrected for Heart Rate (QTc) in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00979316 Org: User:
Start: 09/30/09 End: 02/28/10 Due: 02/28/11

A Study Measuring the Effectiveness, Safety, and Tolerability of BMS-986278 in Participants With Lung Fibrosis

Phase: N/A Priority: Normal
NCT ID: NCT04308681 Org: User:
Start: 07/29/20 End: 09/22/23 Due: 09/22/24

Combination Trial of BMS-690514 in Combination With FOLFIRI and FOLFOX

Phase: N/A Priority: Normal
NCT ID: NCT00479583 Org: User:
Start: 09/30/07 End: 04/30/10 Due: 04/30/11

Study of BMS-354825 in Subjects With CML Who Are Resistant to or Intolerant of Imatinib or Ph+All in Japan

Phase: N/A Priority: Normal
NCT ID: NCT00337454 Org: User:
Start: 07/31/05 End: 03/31/07 Due: 03/31/08

A Study of Cabiralzumab Given by Itself or With Nivolumab in Advanced Cancer or Cancer That Has Spread

Phase: N/A Priority: Normal
NCT ID: NCT03158272 Org: User:
Start: 05/25/17 End: 10/23/19 Due: 10/23/20

Comparative Trial of Entecavir Versus Adefovir in the Treatment of Chronic Hepatitis B Infection

Phase: N/A Priority: Normal
NCT ID: NCT00096785 Org: User:
Start: 12/31/04 End: 04/30/08 Due: 04/30/09

Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00481325 Org: User:
Start: 07/31/07 End: 03/31/08 Due: 03/31/09

A Study of Nivolumab in Combination With Ipilimumab in Participants With Advanced Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04039607 Org: User:
Start: 09/30/19 End: 09/30/26 Due: 09/30/27

A Study to Assess the Drug Levels of Repotrectinib in Healthy Participants and Participants With Moderate and Severe Hepatic Impairment

Phase: N/A Priority: Normal
NCT ID: NCT06352528 Org: User:
Start: 04/29/24 End: 07/24/25 Due: 07/24/26

Drug Interaction & Methadone & Buprenorphine

Phase: N/A Priority: Normal
NCT ID: NCT02045693 Org: User:
Start: 02/28/14 End: 04/30/14 Due: 04/30/15

A Study of Participants With Non-Valvular Atrial Fibrillation (NVAF) Treated or Untreated With Oral Anticoagulant in the National Cerebral and Cardiovascular Center (NCVC) in Japan

Phase: N/A Priority: Normal
NCT ID: NCT05027061 Org: User:
Start: 04/02/21 End: 12/04/21 Due: 12/04/22

Expanded Access for Dasatinib

Phase: N/A Priority: Normal
NCT ID: NCT00454753 Org: User:
Start: - End: - Due: -

An Investigational Study to Determine the Drug Level Profile of BMS-986165 in Healthy Male Volunteers Following Transporter Inhibition.

Phase: N/A Priority: Normal
NCT ID: NCT04086719 Org: User:
Start: 09/12/19 End: 10/29/19 Due: 10/29/20

Neoadjuvant Nivolumab+Ipilimumab Followed by Adjuvant Nivolumab or Neoadjuvant Nivolumab+Ipilimumab Followed by Adjuvant Observation Compared With Adjuvant Nivolumab in Treatment-Naive High-risk Melanoma Participants

Phase: N/A Priority: Normal
NCT ID: NCT04495010 Org: User:
Start: 03/31/21 End: 10/23/27 Due: 10/23/28

Combination Study of BMS-754807 and Herceptin® in Patients With Advanced or Metastatic Her-2-positive Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00788333 Org: User:
Start: 07/31/09 End: 11/30/11 Due: 11/30/12

A Study of BMS-986442 With Nivolumab With or Without Chemotherapy in Solid Tumors and Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05543629 Org: User:
Start: 10/04/22 End: 09/12/24 Due: 09/12/25

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia (CML) or With Ph+ Leukemias Resistant or Intolerant to Imatinib

Phase: N/A Priority: Normal
NCT ID: NCT00777036 Org: User:
Start: 03/20/09 End: 01/27/25 Due: 01/27/26

A Study of Azacitidine in Participants With International Prognostic Scoring System (IPSS) Intermediate-2 and High-risk Myelodysplastic Syndromes (MDS), or Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML)

Phase: N/A Priority: Normal
NCT ID: NCT05218902 Org: User:
Start: 02/25/22 End: 03/20/23 Due: 03/20/24